HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Submucosal Adipose Tumors

Submucosal adipose tumors, also known as lipomas, are benign growths that develop beneath the mucous membrane lining of various organs, commonly found in the gastrointestinal tract. These tumors are composed of mature adipose (fat) tissue and are typically slow-growing, posing minimal threat to overall health. While the exact cause of submucosal adipose tumors remains unclear, they are generally considered non-cancerous and rarely lead to complications. These growths are often discovered incidentally during medical imaging or endoscopic procedures conducted for unrelated reasons. Although they are usually asymptomatic, some individuals may experience symptoms such as abdominal pain, bloating, or changes in bowel habits, depending on the location and size of the tumor. Diagnosis of submucosal adipose tumors involves imaging studies, such as computed tomography (CT) scans or magnetic resonance imaging (MRI). In most cases, medical professionals adopt a conservative approach, closely monitoring the growth without immediate intervention. However, if symptoms are severe or the tumor causes complications, surgical removal may be recommended. The prognosis for individuals with submucosal adipose tumors is generally favorable, as these growths rarely lead to malignancy or serious health issues. Regular follow-up appointments and monitoring are essential to ensure any changes in size or symptoms are promptly addressed. Overall, understanding the nature of submucosal adipose tumors aids healthcare providers in developing appropriate management strategies tailored to each patient's unique circumstances.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp